FDA Inspection 1062937 — Cantrell Drug Company

Cantrell Drug Company — FEI 3004483441

The FDA completed an inspection of Cantrell Drug Company on Aug 22, 2018 in Little Rock, AR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 22, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Little Rock, AR (United States)

Citations

IDCFRDescription
116921 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
126321 CFR 211.68(b)Computer control of master formula records
354721 CFR 211.46(b)Equipment for Environmental Control

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.